Drugs List

Drugs A-Z List - F
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Drugs List [Browse by brand or generic name]
Fabior (tazarotene) - FDA

Description : Fabior (tazarotene) Foam, 0.1% contains the compound tazarotene, a member of the acetylenic...

  • Indications
  • Fabior (tazarotene) Foam, 0.1% is indicated for the topical treatment of acne vulgaris in patients 12 years of age or older.
  •   Read More
Fabior (tazarotene) - FDA

Description : Fabior (tazarotene) Foam, 0.1% contains the compound tazarotene, a member of the acetylenic...

  • Indications
  • Fabior (tazarotene) Foam, 0.1% is indicated for the topical treatment of acne vulgaris in patients 12 years of age or older.
  •   Read More
Fabrazyme  agalsidase beta (Pronunciation: a GAL sih daze BA - FDA

Description : Fabrazyme® (agalsidase beta) is a recombinant human α-galactosidase A enzyme with...

  • Indications
  • Fabrazyme (agalsidase beta) is indicated for use in patients with Fabry disease. Fabrazyme (agalsidase beta) reduces globo-triaosylceramide (GL-3) deposition in capillary endo
  •   Read More
Fabrazyme agalsidase beta (Pronunciation: a GAL sih daze BAY - Multum

Description : Fabrazyme® (agalsidase beta) is a recombinant human α-galactosidase A enzyme with...

  • Indications
  • Fabrazyme (agalsidase beta) is indicated for use in patients with Fabry disease. Fabrazyme (agalsidase beta) reduces globo-triaosylceramide (GL-3) deposition in capillary endo
  •   Read More
Fabrazyme agalsidase beta (Pronunciation: a GAL sih daze BAY - FDA

Description : Fabrazyme® (agalsidase beta) is a recombinant human α-galactosidase A enzyme with...

  • Indications
  • Fabrazyme (agalsidase beta) is indicated for use in patients with Fabry disease. Fabrazyme (agalsidase beta) reduces globo-triaosylceramide (GL-3) deposition in capillary
  •   Read More
Fabrazyme agalsidase beta (Pronunciation: a GAL sih daze BAY - Multum

Description : Fabrazyme® (agalsidase beta) is a recombinant human α-galactosidase A enzyme with...

  • Indications
  • Fabrazyme (agalsidase beta) is indicated for use in patients with Fabry disease. Fabrazyme (agalsidase beta) reduces globo-triaosylceramide (GL-3) deposition in capillary endo
  •   Read More
Factive gemifloxacin (Pronunciation: JEM i FLOX a sin) - FDA

Description : FACTIVE (gemifloxacin mesylate) is a synthetic broad-spectrum antibacterial agent for oral ...

  • Indications
  • FACTIVE is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. (See DOSAGE AND ADMINIS
  •   Read More
Factive gemifloxacin (Pronunciation: JEM i FLOX a sin) - Multum

Description : FACTIVE (gemifloxacin mesylate) is a synthetic broad-spectrum antibacterial agent for oral ...

  • Indications
  • FACTIVE is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. (See DOSAGE AND ADMINIS
  •   Read More
Factive gemifloxacin (Pronunciation: JEM i FLOX a sin) - FDA

Description : FACTIVE (gemifloxacin mesylate) is a synthetic broad-spectrum antibacterial agent for oral ...

  • Indications
  • FACTIVE is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. (See DOSAGE AND ADMINIS
  •   Read More
Factive gemifloxacin (Pronunciation: JEM i FLOX a sin) - Multum

Description : FACTIVE (gemifloxacin mesylate) is a synthetic broad-spectrum antibacterial agent for oral ...

  • Indications
  • FACTIVE is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. (See DOSAGE AND ADMINIS
  •   Read More
Factrel Factrel (gonadorelin) is C 55 H 75 N 17 O 13 HCl, - FDA

Description : An agent for use in evaluating hypothalamic-pituitary gonadotropic function. Factrel (gonad...

  • Indications
  • Factrel (gonadorelin) as a single injection is indicated for evaluating the functional capacity and response of the gonadotropes of the anterior pituitary. This single-inj
  •   Read More
Factrel (gonadorelin hydrochloride) - FDA

Description : An agent for use in evaluating hypothalamic-pituitary gonadotropic function. Factrel (gonad...

  • Indications
  • Factrel (gonadorelin) as a single injection is indicated for evaluating the functional capacity and response of the gonadotropes of the anterior pituitary. This single-inj
  •   Read More
Famotidine Injection The active ingredient in famotidine injection is a - FDA

Description : The active ingredient in famotidine injection is a histamine H2–receptor antagonist. ...

  • Indications
  • Famotidine injection, supplied as a concentrated solution for intravenous injection, is intended for intravenous use only. Famotidine injection is indicated in some hospit
  •   Read More
Famvir famciclovir (Pronunciation: fam SYE klo veer) - FDA

Description : The active ingredient in FAMVIR tablets is famciclovir, an orally administered prodrug of t...

  • Indications
  • Immunocompetent Adult Patients Herpes labialis (cold sores) FAMVIR is indicated for the treatment of recurrent herpes labialis. Genital herpes Recurrent episodes: FAMV
  •   Read More
Famvir famciclovir (Pronunciation: fam SYE klo veer) - Multum

Description : The active ingredient in FAMVIR tablets is famciclovir, an orally administered prodrug of t...

  • Indications
  • Immunocompetent Adult Patients Herpes labialis (cold sores) FAMVIR is indicated for the treatment of recurrent herpes labialis. Genital herpes Recurrent episodes: FAMV
  •   Read More
Famvir famciclovir (Pronunciation: fam SYE klo veer) - FDA

Description : The active ingredient in FAMVIR tablets is famciclovir, an orally administered prodrug of t...

  • Indications
  • Immunocompetent Adult Patients Herpes labialis (cold sores) FAMVIR is indicated for the treatment of recurrent herpes labialis. Genital herpes Recurrent episodes: FAMV
  •   Read More
Famvir famciclovir (Pronunciation: fam SYE klo veer) - Multum

Description : The active ingredient in FAMVIR tablets is famciclovir, an orally administered prodrug of t...

  • Indications
  • Immunocompetent Adult Patients Herpes labialis (cold sores) FAMVIR is indicated for the treatment of recurrent herpes labialis. Genital herpes Recurrent episodes: FAMV
  •   Read More
Fanapt iloperidone (Pronunciation: EYE loe PER i done) - FDA

Description : FANAPT is a psychotropic agent belonging to the chemical class of piperidinyl-benzisoxazole...

  • Indications
  • FANAPT® tablets are indicated for the treatment of adults with schizophrenia. Efficacy was established in two short-term (4-and 6-week) placebo-and active-controlled s
  •   Read More
Fanapt iloperidone (Pronunciation: EYE loe PER i done) - Multum

Description : FANAPT is a psychotropic agent belonging to the chemical class of piperidinyl-benzisoxazole...

  • Indications
  • FANAPT® tablets are indicated for the treatment of adults with schizophrenia. Efficacy was established in two short-term (4-and 6-week) placebo-and active-controlled s
  •   Read More
Fanapt  iloperidone (Pronunciation: EYE loe PER i done - FDA

Description : o off-white finely crystalline powder. It is practically insoluble in water, very slightly solu...

  • Indications
  • FANAPT® tablets are indicated for the treatment of adults with schizophrenia. Efficacy was established in two short-term (4-and 6-week) placebo-and active-controlled s
  •   Read More
Fanapt  iloperidone (Pronunciation: EYE loe PER i done) - Multum

Description : FANAPT is a psychotropic agent belonging to the chemical class of piperidinyl-benzisoxazole...

  • Indications
  • FANAPT® tablets are indicated for the treatment of adults with schizophrenia. Efficacy was established in two short-term (4-and 6-week) placebo-and active-controlled s
  •   Read More
Fansidar pyrimethamine and sulfadoxine (Pronunciation: PIR - FDA

Description : Fansidar (sulfadoxine and pyrimethamine) is an antimalarial agent, each tablet containing 5...

  • Indications
  • Treatment of Acute Malaria Fansidar (sulfadoxine and pyrimethamine) is indicated for the treatment of acute, uncomplicated P. falciparum malaria for those patients in who
  •   Read More
Fansidar pyrimethamine and sulfadoxine (Pronunciation: PIR - Multum

Description : Fansidar (sulfadoxine and pyrimethamine) is an antimalarial agent, each tablet containing 5...

  • Indications
  • Treatment of Acute Malaria Fansidar (sulfadoxine and pyrimethamine) is indicated for the treatment of acute, uncomplicated P. falciparum malaria for those patients in who
  •   Read More
Fansidar pyrimethamine and sulfadoxine (Pronunciation: PIR - FDA

Description : Fansidar (sulfadoxine and pyrimethamine) is an antimalarial agent, each tablet containing 500 m...

  • Indications
  • Treatment of Acute Malaria Fansidar (sulfadoxine and pyrimethamine) is indicated for the treatment of acute, uncomplicated P. falciparum malaria for those patients in who
  •   Read More
Fansidar pyrimethamine and sulfadoxine (Pronunciation: PIR - Multum

Description : Fansidar (sulfadoxine and pyrimethamine) is an antimalarial agent, each tablet containing 500 m...

  • Indications
  • Treatment of Acute Malaria Fansidar (sulfadoxine and pyrimethamine) is indicated for the treatment of acute, uncomplicated P. falciparum malaria for those patients in who
  •   Read More
Fareston toremifene (Pronunciation: tor EH mih feen) - FDA

Description : FARESTON (toremifene citrate) Tablets for oral administration each contain 88.5 mg of torem...

  • Indications
  • FARESTON® is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown
  •   Read More
Fareston toremifene (Pronunciation: tor EH mih feen) - Multum

Description : FARESTON (toremifene citrate) Tablets for oral administration each contain 88.5 mg of torem...

  • Indications
  • FARESTON® is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown
  •   Read More
Fareston  toremifene (Pronunciation: tor EH mih feen) - FDA

Description : FARESTON (toremifene citrate) Tablets for oral administration each contain 88.5 mg of toremifen...

  • Indications
  • FARESTON® is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumo
  •   Read More
Fareston toremifene (Pronunciation: tor EH mih feen) - Multum

Description : FARESTON (toremifene citrate) Tablets for oral administration each contain 88.5 mg of toremifen...

  • Indications
  • FARESTON® is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumo
  •   Read More
Farxiga (dapagliflozin) Film-coated Tablets - FDA

Description : Dapagliflozin is described chemically as D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4ethoxyp...

  • Indications
  • FARXIGA (dapagliflozin) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies]. Limita
  •   Read More
Farxiga  (dapagliflozin) Film-coated Tablets - FDA

Description : Dapagliflozin is described chemically as D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4ethoxyp...

  • Indications
  • FARXIGA (dapagliflozin) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies]. Limita
  •   Read More
Farydak  (panobinostat) Capsules - FDA

Description : FARYDAK (panobinostat lactate) is a histone deacetylase inhibitor. The chemical name of pa...

  • Indications
  • FARYDAK, a histone deacetylase inhibitor, in combination with bortezomib and dexamethasone, is indicated for the treatment of patients with multiple myeloma who have recei
  •   Read More
Faslodex fulvestrant (Pronunciation: ful VES trant) - FDA

Description : FASLODEX® (fulvestrant) injection for intramuscular administration is an estrogen recep...

  • Indications
  • FASLODEX is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen thera
  •   Read More
Faslodex fulvestrant (Pronunciation: ful VES trant) - Multum

Description : FASLODEX® (fulvestrant) injection for intramuscular administration is an estrogen recep...

  • Indications
  • FASLODEX is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen thera
  •   Read More
Faslodex fulvestrant (Pronunciation: ful VES trant) - FDA

Description : FASLODEX® (fulvestrant) injection for intramuscular administration is an estrogen recep...

  • Indications
  • FASLODEX is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen thera
  •   Read More
Faslodex fulvestrant (Pronunciation: ful VES trant) - Multum

Description : FASLODEX® (fulvestrant) injection for intramuscular administration is an estrogen recep...

  • Indications
  • FASLODEX is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen thera
  •   Read More
Fastin (phentermine hydrochloride) Capsule - FDA

Description : Each phentermine hydrochloride capsule contains phentermine hydrochloride, 30 mg (equivalen...

  • Indications
  • Phentermine hydrochloride is indicated in the management of exogenous obesity as a short term (a few weeks) adjunct in a regimen of weight reduction based on caloric restr
  •   Read More
Fastin  (phentermine hydrochloride) Capsule - FDA

Description : Each phentermine hydrochloride capsule contains phentermine hydrochloride, 30 mg (equivalen...

  • Indications
  • Phentermine hydrochloride is indicated in the management of exogenous obesity as a short term (a few weeks) adjunct in a regimen of weight reduction based on caloric restr
  •   Read More
Felbatol felbamate (Pronunciation: fel BAM ate) - FDA

Description : Felbatol® (felbamate) is an antiepileptic available as 400 mg and 600 mg tablets and as...

  • Indications
  • Felbatol® is not indicated as a first line antiepileptic treatment (see WARNINGS). Felbatol® is recommended for use only in those patients who respond inadequately
  •   Read More
Felbatol felbamate (Pronunciation: fel BAM ate) - Multum

Description : Felbatol® (felbamate) is an antiepileptic available as 400 mg and 600 mg tablets and as...

  • Indications
  • Felbatol® is not indicated as a first line antiepileptic treatment (see WARNINGS). Felbatol® is recommended for use only in those patients who respond inadequately
  •   Read More
Felbatol felbamate (Pronunciation: fel BAM ate) - FDA

Description : Felbatol® (felbamate) is an antiepileptic available as 400 mg and 600 mg tablets and as...

  • Indications
  • Felbatol® is not indicated as a first line antiepileptic treatment (see WARNINGS). Felbatol® is recommended for use only in those patients who respond inadequately
  •   Read More
Felbatol felbamate (Pronunciation: fel BAM ate) - Multum

Description : Felbatol® (felbamate) is an antiepileptic available as 400 mg and 600 mg tablets and as...

  • Indications
  • Felbatol® is not indicated as a first line antiepileptic treatment (see WARNINGS). Felbatol® is recommended for use only in those patients who respond inadequately
  •   Read More
Feldene piroxicam (Pronunciation: peer OX i kam) - FDA

Description : FELDENE® contains piroxicam which is a member of the oxicam group of nonsteroidal anti-...

  • Indications
  • Carefully consider the potential benefits and risks of FELDENE (piroxicam) and other treatment options before deciding to use FELDENE (piroxicam) . Use the lowest effectiv
  •   Read More
Feldene piroxicam (Pronunciation: peer OX i kam) - Multum

Description : FELDENE® contains piroxicam which is a member of the oxicam group of nonsteroidal anti-...

  • Indications
  • Carefully consider the potential benefits and risks of FELDENE (piroxicam) and other treatment options before deciding to use FELDENE (piroxicam) . Use the lowest effectiv
  •   Read More
Feldene piroxicam (Pronunciation: peer OX i kam - FDA

Description : FELDENE® contains piroxicam which is a member of the oxicam group of nonsteroidal anti-...

  • Indications
  • Carefully consider the potential benefits and risks of FELDENE (piroxicam) and other treatment options before deciding to use FELDENE (piroxicam) . Use the lowest effectiv
  •   Read More
Feldene piroxicam (Pronunciation: peer OX i kam) - Multum

Description : FELDENE® contains piroxicam which is a member of the oxicam group of nonsteroidal anti-...

  • Indications
  • Carefully consider the potential benefits and risks of FELDENE (piroxicam) and other treatment options before deciding to use FELDENE (piroxicam) . Use the lowest effectiv
  •   Read More
Femara letrozole (Pronunciation: LET roe zol) - FDA

Description : Femara tablets for oral administration contains 2.5 mg of letrozole, a nonsteroidal aromata...

  • Indications
  • Adjuvant Treatment Of Early Breast Cancer Femara (letrozole) is indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast c
  •   Read More
Femara letrozole (Pronunciation: LET roe zol) - Multum

Description : Femara tablets for oral administration contains 2.5 mg of letrozole, a nonsteroidal aromata...

  • Indications
  • Adjuvant Treatment Of Early Breast Cancer Femara (letrozole) is indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast c
  •   Read More
Femara letrozole (Pronunciation: LET roe zol) - FDA

Description : Femara tablets for oral administration contains 2.5 mg of letrozole, a nonsteroidal aromata...

  • Indications
  • Adjuvant Treatment Of Early Breast Cancer Femara (letrozole) is indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast c
  •   Read More
Femara letrozole (Pronunciation: LET roe zol) - Multum

Description : Femara tablets for oral administration contains 2.5 mg of letrozole, a nonsteroidal aromata...

  • Indications
  • Adjuvant Treatment Of Early Breast Cancer Femara (letrozole) is indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast c
  •   Read More
Femcare, Gyne-Lotrimin, Mycelex-G clotrimazole vaginal (Pronunciation: kloe TRIM a z - FDA

Description : Active Ingredient (clotrimazole vaginal cream) Clotrimazole 1% Inactive Ingredient (clot...

  • Indications
  • Clotrimazole Vaginal Cream will cure most vaginal yeast (candida) infections. Clotrimazole Vaginal Cream can kill the yeast that cause vaginal yeast infections and can reliev
  •   Read More
Femcare, Gyne-Lotrimin, Mycelex-G clotrimazole vaginal (Pronunciation: kloe TRIM a z - Multum

Description : Active Ingredient (clotrimazole vaginal cream) Clotrimazole 1% Inactive Ingredient (clot...

  • Indications
  • Clotrimazole Vaginal Cream will cure most vaginal yeast (candida) infections. Clotrimazole Vaginal Cream can kill the yeast that cause vaginal yeast infections and can reliev
  •   Read More
Femhrt, femhrt 1 mg/5 mcg ethinyl estradiol and norethindrone (HRT) (Pronunc - FDA

Description : femhrt (norethindrone acetate/ethinyl estradiol tablets) is a continuous dosage regimen of ...

  • Indications
  • Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause Prevention Of Postmenopausal Osteoporosis Limitation of Use When prescribing solely for the preventi
  •   Read More
Femhrt, femhrt 1 mg/5 mcg ethinyl estradiol and norethindrone (HRT) (Pronunc - Multum

Description : femhrt (norethindrone acetate/ethinyl estradiol tablets) is a continuous dosage regimen of ...

  • Indications
  • Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause Prevention Of Postmenopausal Osteoporosis Limitation of Use When prescribing solely for the preventi
  •   Read More
Femhrt, femhrt 1 mg/5 mcg ethinyl estradiol and norethindrone (HRT) (Pronunc - FDA

Description : femhrt (norethindrone acetate/ethinyl estradiol tablets) is a continuous dosage regimen of ...

  • Indications
  • Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause Prevention Of Postmenopausal Osteoporosis Limitation of Use When prescribing solely for the preventi
  •   Read More
Femhrt, femhrt 1 mg/5 mcg ethinyl estradiol and norethindrone (HRT) (Pronunc - Multum

Description : femhrt (norethindrone acetate/ethinyl estradiol tablets) is a continuous dosage regimen of ...

  • Indications
  • Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause Prevention Of Postmenopausal Osteoporosis Limitation of Use When prescribing solely for the preventi
  •   Read More
Femring estradiol vaginal (systemic) (Pronunciation: ES tr - FDA

Description : Femring (estradiol acetate vaginal ring) is an off-white, soft, flexible ring with a centra...

  • Indications
  • Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause. Treatment Of Moderate To Severe Vulvar And Vaginal Atrophy Due To Menopause.
  •   Read More
Femring estradiol vaginal (systemic) (Pronunciation: ES tr - Multum

Description : Femring (estradiol acetate vaginal ring) is an off-white, soft, flexible ring with a centra...

  • Indications
  • Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause. Treatment Of Moderate To Severe Vulvar And Vaginal Atrophy Due To Menopause.
  •   Read More
Femring estradiol vaginal (systemic) (Pronunciation: ES tr - FDA

Description : Femring (estradiol acetate vaginal ring) is an off-white, soft, flexible ring with a cent...

  • Indications
  • Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause. Treatment Of Moderate To Severe Vulvar And Vaginal Atrophy Due To Menopause.
  •   Read More
Femring estradiol vaginal (systemic) (Pronunciation: ES tr - Multum

Description : Femring (estradiol acetate vaginal ring) is an off-white, soft, flexible ring with a central co...

  • Indications
  • Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause. Treatment Of Moderate To Severe Vulvar And Vaginal Atrophy Due To Menopause.
  •   Read More
Femtrace (estradiol acetate) Tablets - FDA

Description : Femtrace (estradiol acetate tablets) for oral administration are available in the following...

  • Indications
  • Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause
  •   Read More
Femtrace (estradiol acetate) Tablets - FDA

Description : Femtrace (estradiol acetate tablets) for oral administration are available in the following thr...

  • Indications
  • Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause
  •   Read More
Fentora, Onsolis fentanyl (buccal) (Pronunciation: FEN ta nil (BUK - FDA

Description : ONSOLIS (fentanyl buccal soluble film) is an oral transmucosal form of the potent opioid an...

  • Indications
  • ONSOLIS (fentanyl buccal soluble film) is an opioid analgesic indicated only for the management of breakthrough pain in patients with cancer, 18 years of age and older, wh
  •   Read More
Fentora, Onsolis fentanyl (buccal) (Pronunciation: FEN ta nil (BUK - Multum

Description : ONSOLIS (fentanyl buccal soluble film) is an oral transmucosal form of the potent opioid an...

  • Indications
  • ONSOLIS (fentanyl buccal soluble film) is an opioid analgesic indicated only for the management of breakthrough pain in patients with cancer, 18 years of age and older, wh
  •   Read More
Fentora, Onsolis fentanyl (buccal) (Pronunciation: FEN ta nil (BUK - FDA

Description : FENTORA (fentanyl buccal tablet) is a potent opioid analgesic, intended for buccal mucosa...

  • Indications
  • FENTORA is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to around-the-cloc
  •   Read More
Fentora, Onsolis fentanyl (buccal) (Pronunciation: FEN ta nil (BUK - Multum

Description : FENTORA (fentanyl buccal tablet) is a potent opioid analgesic, intended for buccal mucosa...

  • Indications
  • FENTORA is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to around-the-cloc
  •   Read More
Fentora, Onsolis fentanyl (buccal) (Pronunciation: FEN ta nil (BUK - FDA

Description : FENTORA (fentanyl buccal tablet) is a potent opioid analgesic, intended for buccal mucosa...

  • Indications
  • FENTORA is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to around-the-cloc
  •   Read More
Fentora, Onsolis fentanyl (buccal) (Pronunciation: FEN ta nil (BUK - Multum

Description : FENTORA (fentanyl buccal tablet) is a potent opioid analgesic, intended for buccal mucosa...

  • Indications
  • FENTORA is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to around-the-cloc
  •   Read More
Fentora, Onsolis fentanyl (buccal) (Pronunciation: FEN ta nil (BUK - FDA

Description : ONSOLIS (fentanyl buccal soluble film) is an oral transmucosal form of the potent opioid an...

  • Indications
  • ONSOLIS (fentanyl buccal soluble film) is an opioid analgesic indicated only for the management of breakthrough pain in patients with cancer, 18 years of age and older, wh
  •   Read More
Feraheme ferumoxytol (Pronunciation: FER ue MOX i tol) - FDA

Description : Feraheme, an iron replacement product, is a non-stoichiometric magnetite (superparamagnetic...

  • Indications
  • Feraheme is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD).
  •   Read More
Feraheme ferumoxytol (Pronunciation: FER ue MOX i tol) - Multum

Description : Feraheme, an iron replacement product, is a non-stoichiometric magnetite (superparamagnetic...

  • Indications
  • Feraheme is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD).
  •   Read More
Feraheme ferumoxytol (Pronunciation: FER ue MOX i tol) - FDA

Description : Feraheme, an iron replacement product, is a non-stoichiometric magnetite (superparamagnetic...

  • Indications
  • Feraheme is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD).
  •   Read More
Feraheme ferumoxytol (Pronunciation: FER ue MOX i tol) - Multum

Description : Feraheme, an iron replacement product, is a non-stoichiometric magnetite (superparamagnetic...

  • Indications
  • Feraheme is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD).
  •   Read More
Feridex I.V. (ferumoxides) Injectable Solution - FDA

Description : Feridex I.V.® (ferumoxides injectable solution) is a sterile aqueous colloid of superpa...

  • Indications
  • Feridex I.V. (ferumoxides injectable solution) is indicated for I.V. administration as an adjunct to MRI (in adult patients) to enhance the T2 weighted images used in the
  •   Read More
Feridex I.V. (ferumoxides) Injectable Solution - FDA

Description : Feridex I.V.® (ferumoxides injectable solution) is a sterile aqueous colloid of superpa...

  • Indications
  • Feridex I.V. (ferumoxides injectable solution) is indicated for I.V. administration as an adjunct to MRI (in adult patients) to enhance the T2 weighted images used in the dete
  •   Read More
Ferrex 150 Plus, Fe-Tinic 150, Niferex-150 ascorbic acid and iron polysaccharide (Pronunciati - FDA

Description : Each orange film-coated tablet for oral administration contains: Iron   Fer...

  • Indications
  • For the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, m
  •   Read More
Ferrex 150 Plus, Fe-Tinic 150, Niferex-150 ascorbic acid and iron polysaccharide (Pronunciati - Multum

Description : Each orange film-coated tablet for oral administration contains: Iron   Fer...

  • Indications
  • For the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, m
  •   Read More
Ferrex 150 Plus, Fe-Tinic 150, Niferex-150 ascorbic acid and iron polysaccharide (Pronunciati - FDA

Description : Each orange film-coated tablet for oral administration contains: Iron   Fer...

  • Indications
  • For the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, m
  •   Read More
Ferrex 150 Plus, Fe-Tinic 150, Niferex-150 ascorbic acid and iron polysaccharide (Pronunciati - Multum

Description : Each orange film-coated tablet for oral administration contains: Iron   Fer...

  • Indications
  • For the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, m
  •   Read More
Ferrex 150 Plus, Fe-Tinic 150, Niferex-150 ascorbic acid and iron polysaccharide (Pronunciati - FDA

Description : Supplement Facts Serving Size 1 Capsule   Amount Per Serving % Daily Value ...

Ferrex 150 Plus, Fe-Tinic 150, Niferex-150 ascorbic acid and iron polysaccharide (Pronunciati - Multum

Description : Supplement Facts Serving Size 1 Capsule   Amount Per Serving % Daily Value ...

Ferrex 150 Plus, Fe-Tinic 150, Niferex-150 ascorbic acid and iron polysaccharide (Pronunciati - Multum

Description : Supplement Facts Serving Size 1 Capsule   Amount Per Serving % Daily Value ...

Ferriprox deferiprone (Pronunciation: de FER i prone) - FDA

Description : Ferriprox (deferiprone) tablets contain 500 mg deferiprone (3-hydroxy-1,2-dimethylpyridin-4...

  • Indications
  • FERRIPROX® (deferiprone) is indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is in
  •   Read More
Ferriprox deferiprone (Pronunciation: de FER i prone) - FDA

Description : Ferriprox (deferiprone) tablets contain 500 mg deferiprone (3-hydroxy-1,2-dimethylpyridin-4...

  • Indications
  • FERRIPROX® (deferiprone) is indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is in
  •   Read More
Ferriprox deferiprone (Pronunciation: de FER i prone) - Multum

Description : Ferriprox (deferiprone) tablets contain 500 mg deferiprone (3-hydroxy-1,2-dimethylpyridin-4...

  • Indications
  • FERRIPROX® (deferiprone) is indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is in
  •   Read More
Ferrlecit, Nulecit sodium ferric gluconate complex (Pronunciation: SO - FDA

Description : Ferrlecit® (sodium ferric gluconate complex in sucrose injection), an iron replacement ...

  • Indications
  • Ferrlecit is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving
  •   Read More
Ferrlecit, Nulecit sodium ferric gluconate complex (Pronunciation: SO - Multum

Description : Ferrlecit® (sodium ferric gluconate complex in sucrose injection), an iron replacement ...

  • Indications
  • Ferrlecit is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving
  •   Read More
Ferrlecit, Nulecit  sodium ferric gluconate complex (Pronunciation: S - FDA

Description : Ferrlecit® (sodium ferric gluconate complex in sucrose injection), an iron replacement prod...

  • Indications
  • Ferrlecit is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemo
  •   Read More
Ferrlecit, Nulecit sodium ferric gluconate complex (Pronunciation: SO - Multum

Description : Ferrlecit® (sodium ferric gluconate complex in sucrose injection), an iron replacement prod...

  • Indications
  • Ferrlecit is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemo
  •   Read More
Fertinex FertinexTM (urofollitropin for injection, purified - FDA

Description : FertinexTM (urofollitropin for injection, purified) is a preparation of highly purified Follicl...

  • Indications
  • FertinexTM (urofollitropin for injection, purified) and hCG given in a sequential manner are indicated for the stimulation of follicular recruitment and development and th
  •   Read More
Fertinex FertinexTM (urofollitropin for injection, purified - FDA

Description : FertinexTM (urofollitropin for injection, purified) is a preparation of highly purified Follicl...

  • Indications
  • FertinexTM (urofollitropin for injection, purified) and hCG given in a sequential manner are indicated for the stimulation of follicular recruitment and development and th
  •   Read More
Fetzima (levomilnacipran) Extended-release Capsules - FDA

Description : The active ingredient of FETZIMA is levomilnacipran, which is a selective serotonin and nor...

  • Indications
  • FETZIMA, a serotonin and norepinephrine reuptake inhibitor (SNRI) is indicated for the treatment of major depressive disorder (MDD). The efficacy of FETZIMA was establishe
  •   Read More
Fetzima (levomilnacipran) Extended-release Capsules - FDA

Description : The active ingredient of FETZIMA is levomilnacipran, which is a selective serotonin and nor...

  • Indications
  • FETZIMA, a serotonin and norepinephrine reuptake inhibitor (SNRI) is indicated for the treatment of major depressive disorder (MDD). The efficacy of FETZIMA was establishe
  •   Read More
Fibricor, Trilipix fenofibric acid (Pronunciation: FEN oh FYE brik AS - FDA

Description : FIBRICOR is a lipid regulating agent available as tablets for oral administration. Each tab...

  • Indications
  • Severe Hypertriglyceridemia FIBRICOR is indicated as adjunctive therapy to diet for treatment of severe hypertriglyceridemia ( ≥ 500 mg/dL). Improving glycemic control
  •   Read More
Fibricor, Trilipix fenofibric acid (Pronunciation: FEN oh FYE brik AS - Multum

Description : FIBRICOR is a lipid regulating agent available as tablets for oral administration. Each tab...

  • Indications
  • Severe Hypertriglyceridemia FIBRICOR is indicated as adjunctive therapy to diet for treatment of severe hypertriglyceridemia ( ≥ 500 mg/dL). Improving glycemic control
  •   Read More
Fibricor, Trilipix fenofibric acid (Pronunciation: FEN oh FYE brik AS - FDA

Description : Trilipix (fenofibric acid) is a lipid regulating agent available as delayed release capsule...

  • Indications
  • Co-administration Therapy with Statins for the Treatment of Mixed Dyslipidemia Trilipix is indicated as an adjunct to diet in combination with a statin to reduce TG and i
  •   Read More
Fibricor, Trilipix fenofibric acid (Pronunciation: FEN oh FYE brik AS - Multum

Description : Trilipix (fenofibric acid) is a lipid regulating agent available as delayed release capsule...

  • Indications
  • Co-administration Therapy with Statins for the Treatment of Mixed Dyslipidemia Trilipix is indicated as an adjunct to diet in combination with a statin to reduce TG and i
  •   Read More
Fibricor, Trilipix fenofibric acid (Pronunciation: FEN oh FYE brik AS - FDA

Description : FIBRICOR is a lipid regulating agent available as tablets for oral administration. Each tab...

  • Indications
  • Severe Hypertriglyceridemia FIBRICOR is indicated as adjunctive therapy to diet for treatment of severe hypertriglyceridemia ( ≥ 500 mg/dL). Improving glycemic control
  •   Read More
Fibricor, Trilipix fenofibric acid (Pronunciation: FEN oh FYE brik AS - Multum

Description : FIBRICOR is a lipid regulating agent available as tablets for oral administration. Each tab...

  • Indications
  • Severe Hypertriglyceridemia FIBRICOR is indicated as adjunctive therapy to diet for treatment of severe hypertriglyceridemia ( ≥ 500 mg/dL). Improving glycemic control
  •   Read More
Fioricet with Codeine, Phrenilin with Caffeine and Codeine acetaminophen, butalbital, caffeine, and codeine ( - FDA

Description : Fioricet with Codeine (Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate) is suppl...

  • Indications
  • Fioricet with Codeine is indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of Fiori
  •   Read More
Fioricet with Codeine, Phrenilin with Caffeine and Codeine acetaminophen, butalbital, caffeine, and codeine ( - Multum

Description : Fioricet with Codeine (Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate) is suppl...

  • Indications
  • Fioricet with Codeine is indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of Fiori
  •   Read More
Fioricet with Codeine, Phrenilin with Caffeine and Codeine acetaminophen, butalbital, caffeine, and codeine ( - FDA

Description : Fioricet with Codeine (Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate) is suppl...

  • Indications
  • Fioricet with Codeine is indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of Fiori
  •   Read More
Fioricet with Codeine, Phrenilin with Caffeine and Codeine acetaminophen, butalbital, caffeine, and codeine ( - Multum

Description : Fioricet with Codeine (Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate) is suppl...

  • Indications
  • Fioricet with Codeine is indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of Fiori
  •   Read More
Firazyr icatibant (Pronunciation: eye KAT i bant) - FDA

Description : FIRAZYR (icatibant) is a synthetic decapeptide with five non-proteinogenic amino acids. The...

  • Indications
  • FIRAZYR® (icatibant) is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
  •   Read More
Firazyr icatibant (Pronunciation: eye KAT i bant) - Multum

Description : FIRAZYR (icatibant) is a synthetic decapeptide with five non-proteinogenic amino acids. The...

  • Indications
  • FIRAZYR® (icatibant) is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
  •   Read More
Firazyr icatibant (Pronunciation: eye KAT i bant) - FDA

Description : FIRAZYR (icatibant) is a synthetic decapeptide with five non-proteinogenic amino acids. The...

  • Indications
  • FIRAZYR® (icatibant) is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
  •   Read More
Firazyr icatibant (Pronunciation: eye KAT i bant) - Multum

Description : FIRAZYR (icatibant) is a synthetic decapeptide with five non-proteinogenic amino acids. The...

  • Indications
  • FIRAZYR® (icatibant) is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
  •   Read More
Firmagon degarelix) for Injection - FDA

Description : FIRMAGON is a sterile lyophilized powder for injection containing degarelix (as the acetate...

  • Indications
  • FIRMAGON is a GnRH receptor antagonist indicated for treatment of patients with advanced prostate cancer.
  •   Read More
Firmagon (degarelix) for Injection - FDA

Description : FIRMAGON is a sterile lyophilized powder for injection containing degarelix (as the acetate...

  • Indications
  • FIRMAGON is a GnRH receptor antagonist indicated for treatment of patients with advanced prostate cancer.
  •   Read More
First Lansoprazole, Prevacid, Prevacid OTC, Prevacid SoluTab lansoprazole (Pronunciation: lan SOE pra zol) - FDA

Description : The active ingredient in PREVACID Delayed-Release Capsules and PREVACID SoluTab Delayed-Rel...

  • Indications
  • Short-Term Treatment Of Active Duodenal Ulcer PREVACID is indicated for short-term treatment (for 4 weeks) for healing and symptom relief of active duodenal ulcer [see Cl
  •   Read More
First Lansoprazole, Prevacid, Prevacid OTC, Prevacid SoluTab lansoprazole (Pronunciation: lan SOE pra zol) - Multum

Description : The active ingredient in PREVACID Delayed-Release Capsules and PREVACID SoluTab Delayed-Rel...

  • Indications
  • Short-Term Treatment Of Active Duodenal Ulcer PREVACID is indicated for short-term treatment (for 4 weeks) for healing and symptom relief of active duodenal ulcer [see Cl
  •   Read More
First Lansoprazole, Prevacid, Prevacid OTC, Prevacid SoluTab lansoprazole (Pronunciation: lan SOE pra zol) - FDA

Description : The active ingredient in PREVACID Delayed-Release Capsules and PREVACID SoluTab Delayed-Rel...

  • Indications
  • Short-Term Treatment Of Active Duodenal Ulcer PREVACID is indicated for short-term treatment (for 4 weeks) for healing and symptom relief of active duodenal ulcer [see Cl
  •   Read More
First Lansoprazole, Prevacid, Prevacid OTC, Prevacid SoluTab lansoprazole (Pronunciation: lan SOE pra zol) - Multum

Description : The active ingredient in PREVACID Delayed-Release Capsules and PREVACID SoluTab Delayed-Rel...

  • Indications
  • Short-Term Treatment Of Active Duodenal Ulcer PREVACID is indicated for short-term treatment (for 4 weeks) for healing and symptom relief of active duodenal ulcer [see Cl
  •   Read More
FIRST Omeprazole, Prilosec, Prilosec OTC omeprazole (Pronunciation: oh MEP ra zol - FDA

Description : The active ingredient in PRILOSEC (omeprazole) Delayed-Release Capsules is a substituted be...

  • Indications
  • Duodenal Ulcer (adults) PRILOSEC is indicated for short-term treatment of active duodenal ulcer in adults. Most patients heal within four weeks. Some patients may requir
  •   Read More
FIRST Omeprazole, Prilosec, Prilosec OTC omeprazole (Pronunciation: oh MEP ra zol) - FDA

Description : The active ingredient in PRILOSEC (omeprazole) Delayed-Release Capsules is a substituted be...

  • Indications
  • Duodenal Ulcer (adults) PRILOSEC is indicated for short-term treatment of active duodenal ulcer in adults. Most patients heal within four weeks. Some patients may requir
  •   Read More
First Progesterone MC10, First Progesterone MC5, Progest, Prometrium progesterone (Pronunciation: proe JESS te rone) - FDA

Description : PROMETRIUM (progesterone, USP) Capsules contain micronized progesterone for oral administra...

  • Indications
  • PROMETRIUM Capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablet
  •   Read More
First Progesterone MC10, First Progesterone MC5, Progest, Prometrium progesterone (Pronunciation: proe JESS te rone) - Multum

Description : PROMETRIUM (progesterone, USP) Capsules contain micronized progesterone for oral administra...

  • Indications
  • PROMETRIUM Capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablet
  •   Read More
First Progesterone MC10, First Progesterone MC5, Progest, Prometrium progesterone (Pronunciation: proe JESS te rone - FDA

Description : PROMETRIUM (progesterone, USP) Capsules contain micronized progesterone for oral administra...

  • Indications
  • PROMETRIUM Capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablet
  •   Read More
First Progesterone MC10, First Progesterone MC5, Progest, Prometrium progesterone (Pronunciation: proe JESS te rone) - Multum

Description : PROMETRIUM (progesterone, USP) Capsules contain micronized progesterone for oral administra...

  • Indications
  • PROMETRIUM Capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablet
  •   Read More
Flagyl Injection Metronidazole Injection, USP RTU in Plastic Contai - FDA

Description : Metronidazole Injection, USP RTU, is a parenteral dosage form of the synthetic antibacteria...

  • Indications
  • Treatment of Anaerobic Infections Metronidazole Injection, USP RTU is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Indicate
  •   Read More
Flagyl Injection Metronidazole Injection, USP RTU in Plastic Contai - FDA

Description : Metronidazole Injection, USP RTU, is a parenteral dosage form of the synthetic antiba...

  • Indications
  • Treatment of Anaerobic Infections Metronidazole Injection, USP RTU is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Ind
  •   Read More
Flagyl, Flagyl 375, Flagyl ER metronidazole (Pronunciation: me troe NI da zole) - FDA

Description : Flagyl (metronidazole) is an oral synthetic antiprotozoal and antibacterial agent, l-β...

  • Indications
  • Symptomatic Trichomoniasis. Flagyl (metronidazole) is indicated for the treatment of symptomatic trichomoniasis in females and males when the presence of the trichomonad h
  •   Read More
Flagyl, Flagyl 375, Flagyl ER metronidazole (Pronunciation: me troe NI da zole) - Multum

Description : Flagyl (metronidazole) is an oral synthetic antiprotozoal and antibacterial agent, l-β...

  • Indications
  • Symptomatic Trichomoniasis. Flagyl (metronidazole) is indicated for the treatment of symptomatic trichomoniasis in females and males when the presence of the trichomonad h
  •   Read More
Flagyl, Flagyl 375, Flagyl ER metronidazole (Pronunciation: me troe NI da zole) - FDA

Description : FLAGYL metronidazole extended release tablets is an oral formulation of the synthetic nitro...

  • Indications
  • Bacterial Vaginosis (BV). FLAGYL ER 750 mg tablets are indicated in the treatment of BV in non-pregnant women. To reduce the development of drug-resistant bacteria and ma
  •   Read More
Flagyl, Flagyl 375, Flagyl ER metronidazole (Pronunciation: me troe NI da zole) - Multum

Description : FLAGYL metronidazole extended release tablets is an oral formulation of the synthetic nitro...

  • Indications
  • Bacterial Vaginosis (BV). FLAGYL ER 750 mg tablets are indicated in the treatment of BV in non-pregnant women. To reduce the development of drug-resistant bacteria and ma
  •   Read More
Flagyl, Flagyl 375, Flagyl ER metronidazole (Pronunciation: me troe NI da zole) - FDA

Description : FLAGYL (metronidazole) tablets, 250 mg or 500 mg is an oral formulation of the synthetic nitroi...

  • Indications
  • Symptomatic Trichomoniasis FLAGYL is indicated for the treatment of T. vaginalis infection in females and males when the presence of the trichomonad has been confir
  •   Read More
Flagyl, Flagyl 375, Flagyl ER metronidazole (Pronunciation: me troe NI da zole) - Multum

Description : FLAGYL (metronidazole) tablets, 250 mg or 500 mg is an oral formulation of the synthetic nitroi...

  • Indications
  • Symptomatic Trichomoniasis FLAGYL is indicated for the treatment of T. vaginalis infection in females and males when the presence of the trichomonad has been confir
  •   Read More
Flagyl, Flagyl 375, Flagyl ER metronidazole (Pronunciation: me troe NI da zole) - FDA

Description : FLAGYL metronidazole extended release tablets is an oral formulation of the synthetic nitroimid...

  • Indications
  • Bacterial Vaginosis (BV). FLAGYL ER 750 mg tablets are indicated in the treatment of BV in non-pregnant women. To reduce the development of drug-resistant bacteria and m
  •   Read More
Flagyl, Flagyl 375, Flagyl ER metronidazole (Pronunciation: me troe NI da zole) - Multum

Description : FLAGYL metronidazole extended release tablets is an oral formulation of the synthetic nitroimid...

  • Indications
  • Bacterial Vaginosis (BV). FLAGYL ER 750 mg tablets are indicated in the treatment of BV in non-pregnant women. To reduce the development of drug-resistant bacteria
  •   Read More
Flarex, FML Forte Liquifilm, FML Liquifilm, FML S.O.P. fluorometholone ophthalmic (Pronunciation: FLURE o - FDA

Description : FML FORTE® (fluorometholone ophthalmic suspension 0.25%) sterile ophthalmic suspension ...

  • Indications
  • FML FORTE® (fluorometholone ophthalmic suspension 0.25%) suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulba
  •   Read More
Flarex, FML Forte Liquifilm, FML Liquifilm, FML S.O.P. fluorometholone ophthalmic (Pronunciation: FLURE o - Multum

Description : FML FORTE® (fluorometholone ophthalmic suspension 0.25%) sterile ophthalmic suspension ...

  • Indications
  • FML FORTE® (fluorometholone ophthalmic suspension 0.25%) suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulba
  •   Read More
Flarex, FML Forte Liquifilm, FML Liquifilm, FML S.O.P. fluorometholone ophthalmic (Pronunciation: FLURE o - FDA

Description : FML® (fluorometholone ophthalmic suspension, USP) 0.1% is a sterile, topical anti-infla...

  • Indications
  • FML® suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the
  •   Read More
Flarex, FML Forte Liquifilm, FML Liquifilm, FML S.O.P. fluorometholone ophthalmic (Pronunciation: FLURE o - Multum

Description : FML® (fluorometholone ophthalmic suspension, USP) 0.1% is a sterile, topical anti-infla...

  • Indications
  • FML® suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the
  •   Read More
Flarex, FML Forte Liquifilm, FML Liquifilm, FML S.O.P. fluorometholone ophthalmic (Pronunciation: FLURE o - FDA

Description : FML® (fluorometholone ophthalmic suspension, USP) 0.1% is a sterile, topical anti-infla...

  • Indications
  • FML® suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the
  •   Read More
Flarex, FML Forte Liquifilm, FML Liquifilm, FML S.O.P. fluorometholone ophthalmic (Pronunciation: FLURE o - Multum

Description : FML® (fluorometholone ophthalmic suspension, USP) 0.1% is a sterile, topical anti-infla...

  • Indications
  • FML® suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the
  •   Read More
Flarex, FML Forte Liquifilm, FML Liquifilm, FML S.O.P. fluorometholone ophthalmic (Pronunciation: FLURE o - FDA

Description : FML FORTE® (fluorometholone ophthalmic suspension 0.25%) sterile ophthalmic suspension ...

  • Indications
  • FML FORTE® (fluorometholone ophthalmic suspension 0.25%) suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulba
  •   Read More
Flarex, FML Forte Liquifilm, FML Liquifilm, FML S.O.P. fluorometholone ophthalmic (Pronunciation: FLURE o - Multum

Description : FML FORTE® (fluorometholone ophthalmic suspension 0.25%) sterile ophthalmic suspension ...

  • Indications
  • FML FORTE® (fluorometholone ophthalmic suspension 0.25%) suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulba
  •   Read More
Flector Patch diclofenac epolamine) Patch 1.3% - FDA

Description : Flector Patch (diclofenac epolamine topical patch) (10 cm x 14 cm) is comprised of an adhes...

  • Indications
  • Flector® Patch is indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions.
  •   Read More
Flector Patch diclofenac transdermal (Pronunciation: dye KLOE fe - FDA

Description : Flector Patch (diclofenac epolamine topical patch) (10 cm x 14 cm) is comprised of an adhes...

  • Indications
  • Flector® Patch is indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions.
  •   Read More
Flector Patch diclofenac transdermal (Pronunciation: dye KLOE fe - Multum

Description : Flector Patch (diclofenac epolamine topical patch) (10 cm x 14 cm) is comprised of an adhes...

  • Indications
  • Flector® Patch is indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions.
  •   Read More
Fleet Enema, Fleet Enema for Children, OsmoPrep, Visicol sodium biphosphate and sodium phosphate (Pronuncia - FDA

Description : OsmoPrep (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydro...

  • Indications
  • OsmoPrep Tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older.
  •   Read More
Fleet Enema, Fleet Enema for Children, OsmoPrep, Visicol sodium biphosphate and sodium phosphate (Pronuncia - Multum

Description : OsmoPrep (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydro...

  • Indications
  • OsmoPrep Tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older.
  •   Read More
Fleet Enema, Fleet Enema for Children, OsmoPrep, Visicol sodium biphosphate and sodium phosphate (Pronuncia - FDA

Description : Visicol (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, U...

  • Indications
  • Visicol Tablets are indicated for cleansing of the colon as a preparation forcolonoscopy in adults 18 years of age or older.
  •   Read More
Fleet Enema, Fleet Enema for Children, OsmoPrep, Visicol sodium biphosphate and sodium phosphate (Pronuncia - Multum

Description : Visicol (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, U...

  • Indications
  • Visicol Tablets are indicated for cleansing of the colon as a preparation forcolonoscopy in adults 18 years of age or older.
  •   Read More
Fleet Enema, Fleet Enema for Children, OsmoPrep, Visicol sodium biphosphate and sodium phosphate (Pronuncia - FDA

Description : OsmoPrep (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, ...

  • Indications
  • OsmoPrep Tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older.
  •   Read More
Fleet Enema, Fleet Enema for Children, OsmoPrep, Visicol sodium biphosphate and sodium phosphate (Pronuncia - Multum

Description : OsmoPrep (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, ...

  • Indications
  • OsmoPrep Tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older.
  •   Read More
Fleet Enema, Fleet Enema for Children, OsmoPrep, Visicol  sodium biphosphate and sodium phosphate (Pronunci - FDA

Description : Visicol (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, U...

  • Indications
  • Visicol Tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older.
  •   Read More
Fleet Enema, Fleet Enema for Children, OsmoPrep, Visicol sodium biphosphate and sodium phosphate (Pronuncia - Multum

Description : Visicol (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, U...

  • Indications
  • Visicol Tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older.
  •   Read More
Flolan, Veletri epoprostenol (Pronunciation: EE poe PROST en ol) - FDA

Description : FLOLAN (epoprostenol sodium) for Injection is a sterile sodium salt formulated for intraven...

  • Indications
  • FLOLAN (epoprostenol sodium) is indicated for the treatment of pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity. Studies establishing effectiveness i
  •   Read More
Flolan, Veletri epoprostenol (Pronunciation: EE poe PROST en ol) - Multum

Description : FLOLAN (epoprostenol sodium) for Injection is a sterile sodium salt formulated for intraven...

  • Indications
  • FLOLAN (epoprostenol sodium) is indicated for the treatment of pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity. Studies establishing effectivene
  •   Read More
Flolan, Veletri epoprostenol (Pronunciation: EE poe PROST en ol) - FDA

Description : FLOLAN (epoprostenol sodium) for Injection is a sterile sodium salt formulated for intravenous ...

  • Indications
  • FLOLAN (epoprostenol sodium) is indicated for the treatment of pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity. Studies establishing effec
  •   Read More
Flolan, Veletri epoprostenol (Pronunciation: EE poe PROST en ol) - Multum

Description : FLOLAN (epoprostenol sodium) for Injection is a sterile sodium salt formulated for intravenous ...

  • Indications
  • FLOLAN (epoprostenol sodium) is indicated for the treatment of pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity. Studies establishing effec
  •   Read More
Flomax tamsulosin (Pronunciation: tam soo LOE sin) - Multum

Description : Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate. Tamsul...

  • Indications
  • Flomax® (tamsulosin hydrochloride) capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies]. FLO
  •   Read More
Flomax tamsulosin (Pronunciation: tam soo LOE sin) - FDA

Description : Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate. Tamsul...

  • Indications
  • Flomax® (tamsulosin hydrochloride) capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies]. FLOMAX
  •   Read More
Flonase, Veramyst fluticasone nasal (Pronunciation: floo TIK a sone) - FDA

Description : Fluticasone propionate, the active component of FLONASE (fluticasone propionate) Nasal Spra...

  • Indications
  • FLONASE (fluticasone propionate) Nasal Spray is indicated for the management of the nasal symptoms of seasonal and perennial allergic and nonallergic rhinitis in adults an
  •   Read More
Flonase, Veramyst fluticasone nasal (Pronunciation: floo TIK a sone) - Multum

Description : Fluticasone propionate, the active component of FLONASE (fluticasone propionate) Nasal Spra...

  • Indications
  • FLONASE (fluticasone propionate) Nasal Spray is indicated for the management of the nasal symptoms of seasonal and perennial allergic and nonallergic rhinitis in adults an
  •   Read More
Flonase, Veramyst fluticasone nasal (Pronunciation: floo TIK a sone) - FDA

Description : Fluticasone furoate, the active component of VERAMYST Nasal Spray, is a synthetic fluorinat...

  • Indications
  • Treatment of Allergic Rhinitis VERAMYST® (fluticasone furoate) Nasal Spray is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis
  •   Read More
Flonase, Veramyst fluticasone nasal (Pronunciation: floo TIK a sone) - Multum

Description : Fluticasone furoate, the active component of VERAMYST Nasal Spray, is a synthetic fluorinat...

  • Indications
  • Treatment of Allergic Rhinitis VERAMYST® (fluticasone furoate) Nasal Spray is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis
  •   Read More
Flonase, Veramyst fluticasone nasal (Pronunciation: floo TIK a sone) - FDA

Description : Fluticasone propionate, the active component of FLONASE (fluticasone propionate) Nasal Spra...

  • Indications
  • FLONASE (fluticasone propionate) Nasal Spray is indicated for the management of the nasal symptoms of seasonal and perennial allergic and nonallergic rhinitis in adults an
  •   Read More
Flonase, Veramyst fluticasone nasal (Pronunciation: floo TIK a sone) - Multum

Description : Fluticasone propionate, the active component of FLONASE (fluticasone propionate) Nasal Spra...

  • Indications
  • FLONASE (fluticasone propionate) Nasal Spray is indicated for the management of the nasal symptoms of seasonal and perennial allergic and nonallergic rhinitis in adults an
  •   Read More
Flonase, Veramyst fluticasone nasal (Pronunciation: floo TIK a sone) - FDA

Description : Fluticasone furoate, the active component of VERAMYST Nasal Spray, is a synthetic fluorina...

  • Indications
  • Treatment Of Allergic Rhinitis VERAMYST® (fluticasone furoate) Nasal Spray is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis
  •   Read More
Flonase, Veramyst fluticasone nasal (Pronunciation: floo TIK a sone) - Multum

Description : Fluticasone furoate, the active component of VERAMYST Nasal Spray, is a synthetic fluorina...

  • Indications
  • Treatment Of Allergic Rhinitis VERAMYST® (fluticasone furoate) Nasal Spray is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis
  •   Read More
Florinef Acetate fludrocortisone (Pronunciation: FLOO droe KOR ti s - FDA

Description : Florinef Acetate (Fludrocortisone Acetate Tablets USP) contains fludrocortisone acetate, a ...

  • Indications
  • Florinef (fludrocortisone) Acetate is indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the trea
  •   Read More
Florinef Acetate fludrocortisone (Pronunciation: FLOO droe KOR ti s - Multum

Description : Florinef Acetate (Fludrocortisone Acetate Tablets USP) contains fludrocortisone acetate, a ...

  • Indications
  • Florinef (fludrocortisone) Acetate is indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the trea
  •   Read More
Florinef Acetate fludrocortisone (Pronunciation: FLOO droe KOR ti s - FDA

Description : Florinef Acetate (Fludrocortisone Acetate Tablets USP) contains fludrocortisone acetate, a ...

  • Indications
  • Florinef (fludrocortisone) Acetate is indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the trea
  •   Read More
Florinef Acetate fludrocortisone (Pronunciation: FLOO droe KOR ti s - Multum

Description : Florinef Acetate (Fludrocortisone Acetate Tablets USP) contains fludrocortisone acetate, a ...

  • Indications
  • Florinef (fludrocortisone) Acetate is indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatmen
  •   Read More
Flovent (fluticasone propionate, 44 mcg) Inhalation Aeroso - FDA

Description : The active component of FLOVENT (fluticasone propionate) 44 mcg Inhalation Aerosol, FLOVENT...

  • Indications
  • FLOVENT (fluticasone propionate) Inhalation Aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy. It is also indicated for patients requiri
  •   Read More
Flovent  (fluticasone propionate, 44 mcg) Inhalation Aeros - FDA

Description : The active component of FLOVENT (fluticasone propionate) 44 mcg Inhalation Aerosol, FLOVENT...

  • Indications
  • FLOVENT (fluticasone propionate) Inhalation Aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy. It is also indicated for patients requiri
  •   Read More
Flovent Diskus, Flovent HFA fluticasone inhalation (Pronunciation: floo TIK a - FDA

Description : The active component of FLOVENT DISKUS 50 mcg, FLOVENT DISKUS 100 mcg, and FLOVENT DISKUS 2...

  • Indications
  • FLOVENT® DISKUS® is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. It is also indicated for patients
  •   Read More
Flovent Diskus, Flovent HFA fluticasone inhalation (Pronunciation: floo TIK a - Multum

Description : The active component of FLOVENT DISKUS 50 mcg, FLOVENT DISKUS 100 mcg, and FLOVENT DISKUS 2...

  • Indications
  • FLOVENT® DISKUS® is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. It is also indicated for patients
  •   Read More
Flovent Diskus, Flovent HFA fluticasone inhalation (Pronunciation: floo TIK a - FDA

Description : The active component of FLOVENT HFA 44 mcg Inhalation Aerosol, FLOVENT HFA 110 mcg Inhalati...

  • Indications
  • FLOVENT® HFA Inhalation Aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. It is also indicated f
  •   Read More
Flovent Diskus, Flovent HFA fluticasone inhalation (Pronunciation: floo TIK a - Multum

Description : The active component of FLOVENT HFA 44 mcg Inhalation Aerosol, FLOVENT HFA 110 mcg Inhalati...

  • Indications
  • FLOVENT® HFA Inhalation Aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. It is also indicated f
  •   Read More
Flovent Diskus, Flovent HFA fluticasone inhalation (Pronunciation: floo TIK a - FDA

Description : The active component of FLOVENT HFA 44 mcg Inhalation Aerosol, FLOVENT HFA 110 mcg Inhalati...

  • Indications
  • FLOVENT® HFA Inhalation Aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. It is also indicated f
  •   Read More
Flovent Diskus, Flovent HFA fluticasone inhalation (Pronunciation: floo TIK a - Multum

Description : The active component of FLOVENT HFA 44 mcg Inhalation Aerosol, FLOVENT HFA 110 mcg Inhalati...

  • Indications
  • FLOVENT® HFA Inhalation Aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. It is also indicated f
  •   Read More
Flovent Diskus, Flovent HFA fluticasone inhalation (Pronunciation: floo TIK a - FDA

Description : The active component of FLOVENT DISKUS 50 mcg, FLOVENT DISKUS 100 mcg, and FLOVENT DISKUS 2...

  • Indications
  • FLOVENT® DISKUS® is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. It is also indicated for patients
  •   Read More
Flovent Diskus, Flovent HFA fluticasone inhalation (Pronunciation: floo TIK a - Multum

Description : The active component of FLOVENT DISKUS 50 mcg, FLOVENT DISKUS 100 mcg, and FLOVENT DISKUS 2...

  • Indications
  • FLOVENT® DISKUS® is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. It is also indicated for patients
  •   Read More
Flovent Diskus, Flovent HFA fluticasone inhalation (Pronunciation: floo TIK a - FDA

Description : The active component of FLOVENT HFA 44 mcg Inhalation Aerosol, FLOVENT HFA 110 mcg Inhalati...

  • Indications
  • FLOVENT® HFA Inhalation Aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. It is also indicated f
  •   Read More
Flovent Diskus, Flovent HFA fluticasone inhalation (Pronunciation: floo TIK a - Multum

Description : The active component of FLOVENT HFA 44 mcg Inhalation Aerosol, FLOVENT HFA 110 mcg Inhalati...

  • Indications
  • FLOVENT® HFA Inhalation Aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. It is also indicated f
  •   Read More
Floxin ofloxacin (Pronunciation: oh FLOX a sin) - FDA

Description : FLOXIN® (ofloxacin tablets) Tablets is a synthetic broad-spectrum antimicrobial agent f...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of FLOXIN® (ofloxacin tablets) Tablets and other antibacterial drugs, FLOXIN® (
  •   Read More
Floxin ofloxacin (Pronunciation: oh FLOX a sin) - Multum

Description : FLOXIN® (ofloxacin tablets) Tablets is a synthetic broad-spectrum antimicrobial agent f...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of FLOXIN® (ofloxacin tablets) Tablets and other antibacterial drugs, FLOXIN® (
  •   Read More
Floxin ofloxacin (Pronunciation: oh FLOX a sin - FDA

Description : FLOXIN® (ofloxacin tablets) Tablets is a synthetic broad-spectrum antimicrobial agent f...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of FLOXIN® (ofloxacin tablets) Tablets and other antibacterial drugs, FLOXIN® (
  •   Read More
Floxin  ofloxacin (Pronunciation: oh FLOX a sin) - Multum

Description : FLOXIN® (ofloxacin tablets) Tablets is a synthetic broad-spectrum antimicrobial agent f...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of FLOXIN® (ofloxacin tablets) Tablets and other antibacterial drugs, FLOXIN® (
  •   Read More
Floxin Otic ofloxacin otic (Pronunciation: oh FLOCKS a sin OH - FDA

Description : FLOXIN® Otic (ofloxacin otic) solution 0.3% is a sterile aqueous anti-infective (anti-b...

  • Indications
  • FLOXIN® Otic (ofloxacin otic) solution 0.3% is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specifi
  •   Read More
Floxin Otic ofloxacin otic (Pronunciation: oh FLOCKS a sin OH - Multum

Description : LOXIN® Otic (ofloxacin otic) solution 0.3% is a sterile aqueous anti-infective (anti-bacter...

  • Indications
  • FLOXIN® Otic (ofloxacin otic) solution 0.3% is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specifi
  •   Read More
Floxin Otic ofloxacin otic (Pronunciation: oh FLOCKS a sin OH - FDA

Description : FLOXIN® Otic SINGLES™ (ofloxacin otic) solution 0.3% is a sterile aqueous anti-in...

  • Indications
  • FLOXIN® Otic SINGLES™ (ofloxacin otic) solution 0.3% is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms
  •   Read More
Floxin Otic ofloxacin otic (Pronunciation: oh FLOCKS a sin OH - Multum

Description : FLOXIN® Otic SINGLES™ (ofloxacin otic) solution 0.3% is a sterile aqueous anti-in...

  • Indications
  • FLOXIN® Otic SINGLES™ (ofloxacin otic) solution 0.3% is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms
  •   Read More
Floxin Otic  ofloxacin otic (Pronunciation: oh FLOCKS a sin OH - FDA

Description : FLOXIN® Otic (ofloxacin otic) solution 0.3% is a sterile aqueous anti-infective (anti-b...

  • Indications
  • FLOXIN® Otic (ofloxacin otic) solution 0.3% is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specifi
  •   Read More
Floxin Otic ofloxacin otic (Pronunciation: oh FLOCKS a sin OH - Multum

Description : FLOXIN® Otic (ofloxacin otic) solution 0.3% is a sterile aqueous anti-infective (anti-b...

  • Indications
  • FLOXIN® Otic (ofloxacin otic) solution 0.3% is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specifi
  •   Read More
Floxin Otic ofloxacin otic (Pronunciation: oh FLOCKS a sin OH - FDA

Description : FLOXIN® Otic SINGLES™ (ofloxacin otic) solution 0.3% is a sterile aqueous anti-in...

  • Indications
  • FLOXIN® Otic SINGLES™ (ofloxacin otic) solution 0.3% is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms
  •   Read More
Floxin Otic ofloxacin otic (Pronunciation: oh FLOCKS a sin OH - Multum

Description : FLOXIN® Otic SINGLES™ (ofloxacin otic) solution 0.3% is a sterile aqueous anti-in...

  • Indications
  • FLOXIN® Otic SINGLES™ (ofloxacin otic) solution 0.3% is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms
  •   Read More
Flublok (Influenza Vaccine) for Intramuscular Injection - FDA

Description : Flublok [Influenza Vaccine] is a sterile, clear, colorless solution of recombinant hemagglu...

  • Indications
  • Flublok is a vaccine indicated for active immunization against disease caused by influenza virus subtypes A and type B contained in the vaccine. Flublok is approved for u
  •   Read More
Flublok Influenza Vaccine) for Intramuscular Injection - FDA

Description : Flublok [Influenza Vaccine] is a sterile, clear, colorless solution of recombinant hemagglu...

  • Indications
  • Flublok is a vaccine indicated for active immunization against disease caused by influenza virus subtypes A and type B contained in the vaccine. Flublok is approved for use i
  •   Read More
Flucelvax (Influenza Vaccine) for Intramuscular Injection - FDA

Description : FLUCELVAX (Influenza Vaccine), a vaccine for intramuscular injection, is a “subunit&r...

  • Indications
  • FLUCELVAX® is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contain
  •   Read More
Flucelvax Influenza Vaccine) for Intramuscular Injection - FDA

Description : FLUCELVAX (Influenza Vaccine), a vaccine for intramuscular injection, is a “subunit&r...

  • Indications
  • FLUCELVAX® is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contain
  •   Read More
Fludara fludarabine (injection) (Pronunciation: floo DAR a - FDA

Description : FLUDARA FOR INJECTION contains fludara (fludarabine) bine phosphate, a fluorinated nucleoti...

  • Indications
  • FLUDARA (fludarabine) FOR INJECTION is indicated for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose dise
  •   Read More
Fludara fludarabine (injection) (Pronunciation: floo DAR a - Multum

Description : FLUDARA FOR INJECTION contains fludara (fludarabine) bine phosphate, a fluorinated nucleoti...

  • Indications
  • FLUDARA (fludarabine) FOR INJECTION is indicated for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose dise
  •   Read More
Fludara fludarabine (injection) (Pronunciation: floo DAR a - FDA

Description : FLUDARA FOR INJECTION contains fludara (fludarabine) bine phosphate, a fluorinated nucleoti...

  • Indications
  • FLUDARA (fludarabine) FOR INJECTION is indicated for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose dise
  •   Read More
Fludara fludarabine (injection) (Pronunciation: floo DAR a - Multum

Description : FLUDARA FOR INJECTION contains fludara (fludarabine) bine phosphate, a fluorinated nucleoti...

  • Indications
  • FLUDARA (fludarabine) FOR INJECTION is indicated for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose dise
  •   Read More
Fludeoxyglucose F 18 Injection Diagnostic - For Intravenous Use Only - FDA

Description : Fludeoxyglucose F 18 Injection (fdg) is a positron emitting radiopharmaceutical containing ...

  • Indications
  • Fludeoxyglucose F 18 Injection (fdg) is indicated in positron emission tomography (PET) imaging for assessment of abnormal glucose metabolism to assist in the evaluation o
  •   Read More
Fludeoxyglucose F 18 Injection Diagnostic - For Intravenous Use Only - FDA

Description : Fludeoxyglucose F 18 Injection (fdg) is a positron emitting radiopharmaceutical containing ...

  • Indications
  • Fludeoxyglucose F 18 Injection (fdg) is indicated in positron emission tomography (PET) imaging for assessment of abnormal glucose metabolism to assist in the evaluation o
  •   Read More
Rx Scoops
Featured Topics
Advertisements
Copyrights ©2014: Rx Scoops - Designed & Developed By - GOIGI